Cardiac disease in pregnancy and hypertension: Difference between revisions
Created page with "{{Pregnancy and heart disease}} {{CMG}}; '''Associate Editor-In-Chief:''' {{AC}} ==References== {{Reflist|2}} Category:Cardiology Category:Obstetrics [[Category:Dis..." |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Pregnancy and heart disease}} | {{Pregnancy and heart disease}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{AC}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{AC}} Stacie Zelman, M.D. [mailto:szelman@wfumbc.edu] | ||
==Overview== | |||
Hypertension in pregnancy can be broadly classified as chronic hypertension, pregnancy-induced hypertension (or gestational hypertension), and pre-eclampsia/eclampsia. All of these conditions are the source of significant maternal morbidity and mortality. | |||
==Chronic [[Hypertension]] in Pregnancy== | |||
This condition is defined as [[hypertension]] (blood pressure ≥140 mm Hg systolic or ≥90 mm Hg diastolic) present before pregnancy or that is diagnosed before the 20th week of gestation. In general, antihypertensive medications are effective in treating this condition, in contrast to pre-eclampsia.<ref name="pmid10920346">{{cite journal| author=| title=Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. | journal=Am J Obstet Gynecol | year= 2000 | volume= 183 | issue= 1 | pages= S1-S22 | pmid=10920346 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10920346 }} </ref> | |||
Safe anti-hypertensive drugs that can be used during pregnancy include; | |||
:#Calcium channel blockers | |||
:#Lasix | |||
:#Beta-blockers | |||
:#Hydralazine | |||
:#Methyldopa | |||
For a more broad discussion of chronic hypertension, click [[hypertension|here]]. | |||
==[[Pregnancy-Induced Hypertension]]== | |||
Pregnancy-induced hypertension (PIH) (or gestational hypertension) is defined as the development of new arterial hypertension in a pregnant woman after 20 weeks gestation. There is no specific treatment, but is monitored closely to rapidly identify [[pre-eclampsia]] and its life-threatening complications (HELLP syndrome and [[eclampsia]]). Treatment options are limited, as many antihypertensives may negatively affect the fetus; methyldopa and labetalol are most commonly used for severe pregnancy hypertension. | |||
==Pre-Eclampsia/Eclampsia== | |||
Revision as of 15:46, 25 October 2011
|
Cardiac disease in pregnancy Microchapters |
|
Diagnosis |
|---|
|
Catheterization: |
|
Treatment |
|
Special Scenarios:
|
|
Cardiac disease in pregnancy and hypertension On the Web |
|
American Roentgen Ray Society Images of Cardiac disease in pregnancy and hypertension |
|
Directions to Hospitals Treating Cardiac disease in pregnancy |
|
Risk calculators and risk factors for Cardiac disease in pregnancy and hypertension |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Anjan K. Chakrabarti, M.D. [2] Stacie Zelman, M.D. [3]
Overview
Hypertension in pregnancy can be broadly classified as chronic hypertension, pregnancy-induced hypertension (or gestational hypertension), and pre-eclampsia/eclampsia. All of these conditions are the source of significant maternal morbidity and mortality.
Chronic Hypertension in Pregnancy
This condition is defined as hypertension (blood pressure ≥140 mm Hg systolic or ≥90 mm Hg diastolic) present before pregnancy or that is diagnosed before the 20th week of gestation. In general, antihypertensive medications are effective in treating this condition, in contrast to pre-eclampsia.[1]
Safe anti-hypertensive drugs that can be used during pregnancy include;
- Calcium channel blockers
- Lasix
- Beta-blockers
- Hydralazine
- Methyldopa
For a more broad discussion of chronic hypertension, click here.
Pregnancy-Induced Hypertension
Pregnancy-induced hypertension (PIH) (or gestational hypertension) is defined as the development of new arterial hypertension in a pregnant woman after 20 weeks gestation. There is no specific treatment, but is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications (HELLP syndrome and eclampsia). Treatment options are limited, as many antihypertensives may negatively affect the fetus; methyldopa and labetalol are most commonly used for severe pregnancy hypertension.
Pre-Eclampsia/Eclampsia
References
- ↑ "Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy". Am J Obstet Gynecol. 183 (1): S1–S22. 2000. PMID 10920346.